Navigation Links
Gamma interferon could aid fight against fungal infections
Date:10/31/2007

Interferon, the superhero cure for viral infections, may be a strong weapon in the battle against fungal infections in immunocompromised patients, according to an article in the November issue of Microbiology Today.

Fungal infections (mycoses) were once seen as exotic diseases, but this is changing rapidly. Although rarely life-threatening in healthy patients, fungal infections are a major problem for the immunocompromised, including HIV patients and people receiving chemotherapy for cancer. Treatment is becoming difficult due to fungal resistance to the antifungal therapy, the variety of disease-causing fungi found and the toxic effects of conventional therapy.

Now, scientists believe gamma interferon, a protein molecule produced by human cells in response to infections, may help to fight fungal infections. Immune cells called neutrophils are rapidly recruited to the site of infection and play an essential role in fungal killing, say Drs. Javier Capilla, Karl Clemons and David Stevens, of Santa Clara Valley Medical Center, Stanford Medical School and the California Institute for Medical Research. Gamma interferon enhances the mechanisms of these cells to make them more potent killers of fungi.

Tests on many fungal infections, including blastomycosis, candidosis and aspergillosis have shown that gamma interferon has beneficial effects in terms of the reduction of the fungus in the organs and on animal survival. But according to Dr Stevens, interferon is not the only answer. Therapy using gamma interferon alone has failed to clear the fungus completely from infected tissues but it has great potential to add to conventional therapy.

When gamma interferon was given to mice infected with Cryptococcus along with amphotericin B, a standard antifungal treatment, the rate of cure was significantly higher than using one therapy alone. We need to look at the route of administration, the frequency of dosing and the dosage given before we can determine fully the use of gamma interferon as an adjunctive therapy.

There is still work to be done. We explored the possibility of using gene therapy for delivering gamma interferon into the nervous system to combat fungal meningitis. Studies of this type suggest a potential clinical use for specific gamma interferon gene therapy in the future. Treatment with gamma-interferon offers a new additional approach to treatment and it provides a new approach to treating difficult diseases. However, clinical trials must document the benefit for patients says Dr Stevens.

Other features in the November 2007 issue of Microbiology Today include:

  • Interferon: The Early Days (page 156)
  • Viruses and Interferon 50 years on (page 160)
  • Chemokines, receptors and virus infection (page 164)
  • Gamma interferon key, but not sufficient for protection against TB" (page 172)
  • Comment: Microbiology a degree of concern (page 200)

These are just some of the articles that appear, together with all the regular features and reports of Society activities.


'/>"/>

Contact: Lucy Goodchild
l.goodchild@sgm.ac.uk
01-189-881-843
Society for General Microbiology
Source:Eurekalert

Related biology news :

1. Genes In The Interferon System Important In Systemic Lupus Erythematosus
2. Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients
3. Hepatitis C responds best to combo of ribavirin and interferon, study concludes
4. Newfound roadblock to interferon effectiveness against malignant melanoma
5. Greasing interferons gears may pave way to greater therapeutic benefits, fewer side effects
6. Protein discovery could unlock the secret to better TB treatment
7. Tiny particles could solve billion-dollar problem
8. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
9. Spider Venom Could Yield Eco-Friendly Insecticides
10. First atlas of key brain genes could speed research on cancer, neurological diseases
11. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... 22, 2016 On Monday, the Department of ... to share solutions for the Biometric Exit Program. The ... Border Protection (CBP), explains that CBP intends to add ... the United States , in order to ... imposters. Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
Breaking Biology News(10 mins):
(Date:12/6/2016)... ... December 06, 2016 , ... ... building management solutions headquartered in Aurora, Ohio, announced the opening of their new ... Carolina, the newly constructed facility is home to 200 employees focused on providing ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... ... MA to soon resume cervical and lumbar disc production, company President, Jake Lubinski ... surgeons who are implanting the AxioMed disc in Cologne and Karlsruhe to discuss ...
(Date:12/5/2016)... Dec. 5, 2016  Eisai Inc. announced today ... study of rufinamide, which were presented at the ... (AES) held from December 2-6 in ... safety, tolerability and cognitive data showed that patients ... safety and tolerability profiles, cognitive development and behavior, ...
(Date:12/4/2016)... 3, 2016  In five studies being presented today ... Meeting and Exposition in San Diego ... improve the delivery of life-saving treatments to patients with ... designed to carry therapies directly to the sites in ... provide a substantial advantage over traditional, systemic methods. The ...
Breaking Biology Technology: